000 | 01948 a2200541 4500 | ||
---|---|---|---|
005 | 20250517093634.0 | ||
264 | 0 | _c20170626 | |
008 | 201706s 0 0 eng d | ||
022 | _a1759-5037 | ||
024 | 7 |
_a10.1038/nrendo.2016.55 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKristensen, David M | |
245 | 0 | 0 |
_aAnalgesic use - prevalence, biomonitoring and endocrine and reproductive effects. _h[electronic resource] |
260 |
_bNature reviews. Endocrinology _c07 2016 |
||
300 |
_a381-93 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetaminophen _xanalysis |
650 | 0 | 4 |
_aAnalgesics, Non-Narcotic _xanalysis |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xanalysis |
650 | 0 | 4 |
_aAspirin _xanalysis |
650 | 0 | 4 |
_aCommerce _xstatistics & numerical data |
650 | 0 | 4 |
_aCongenital Abnormalities _xepidemiology |
650 | 0 | 4 | _aDrug Monitoring |
650 | 0 | 4 |
_aEndocrine Disruptors _xtherapeutic use |
650 | 0 | 4 | _aEnvironmental Exposure |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIbuprofen _xtherapeutic use |
650 | 0 | 4 |
_aMeconium _xchemistry |
650 | 0 | 4 |
_aMilk, Human _xchemistry |
650 | 0 | 4 |
_aMolar _xchemistry |
650 | 0 | 4 |
_aPain _xdrug therapy |
650 | 0 | 4 | _aPain Management |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Outcome _xepidemiology |
650 | 0 | 4 |
_aPrenatal Exposure Delayed Effects _xepidemiology |
650 | 0 | 4 |
_aSalicylic Acid _xmetabolism |
650 | 0 | 4 |
_aTooth, Deciduous _xchemistry |
650 | 0 | 4 |
_aUrogenital Abnormalities _xepidemiology |
700 | 1 | _aMazaud-Guittot, Séverine | |
700 | 1 | _aGaudriault, Pierre | |
700 | 1 | _aLesné, Laurianne | |
700 | 1 | _aSerrano, Tania | |
700 | 1 | _aMain, Katharina M | |
700 | 1 | _aJégou, Bernard | |
773 | 0 |
_tNature reviews. Endocrinology _gvol. 12 _gno. 7 _gp. 381-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrendo.2016.55 _zAvailable from publisher's website |
999 |
_c25992534 _d25992534 |